analyst
NS
AMEX · NSRX
Nasus Pharma Ltd.
Healthcare · Biotechnology
$3.20
Down-$0.20 (-6.25%)
Updated Nov 4, 2026, 8:01 PM
SID Score
2.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 58.89M
- P/E ratio
- -38.44
- Dividend yield
- 0.00%
- 52-week range
- $1.98 – $5.20
- Volume
- 15.74K
- Avg. volume
- 13.21K
Price performance · NSRX
NSRX price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
NSRX closed at $3.20 after 21 trading sessions, down 16.67% for the selected period.
- Last close
- $3.20
- Period change
- -16.67%
- Period low
- $3.06
- Period high
- $3.84
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $3.31 | $3.395 | $3.10 | $3.20 | 15.74K |
| Nov 2, 2026 | $3.10 | $3.32 | $3.10 | $3.1991 | 4.75K |
| Oct 30, 2026 | $3.23 | $3.27 | $3.07 | $3.07 | 4.89K |
| Oct 29, 2026 | $3.34 | $3.40 | $3.19 | $3.19 | 10.58K |
| Oct 28, 2026 | $3.39 | $3.40 | $3.19 | $3.34 | 5.39K |
| Oct 27, 2026 | $3.2846 | $3.50 | $3.2846 | $3.32 | 10.98K |
| Oct 26, 2026 | $3.41 | $3.6067 | $3.41 | $3.49 | 15.05K |
| Oct 23, 2026 | $3.20 | $3.585 | $3.09 | $3.49 | 35.24K |
| Oct 22, 2026 | $3.31 | $3.61 | $3.12 | $3.23 | 33.36K |
| Oct 21, 2026 | $3.20 | $3.63 | $3.03 | $3.06 | 44.42K |
| Oct 20, 2026 | $3.21 | $3.33 | $3.21 | $3.24 | 19.85K |
| Oct 19, 2026 | $3.13 | $3.39 | $3.09 | $3.205 | 19.08K |
| Oct 16, 2026 | $3.0901 | $3.24 | $3.0901 | $3.18 | 15.04K |
| Oct 15, 2026 | $3.22 | $3.22 | $3.0501 | $3.165 | 6.52K |
| Oct 14, 2026 | $3.23 | $3.3099 | $3.08 | $3.18 | 13.34K |
| Oct 13, 2026 | $3.22 | $3.33 | $3.10 | $3.16 | 13.42K |
| Oct 12, 2026 | $3.33 | $3.44 | $3.2423 | $3.32 | 30.88K |
| Oct 9, 2026 | $3.63 | $3.6612 | $3.44 | $3.51 | 16.92K |
| Oct 8, 2026 | $3.78 | $3.78 | $3.50 | $3.63 | 14.03K |
| Oct 7, 2026 | $3.855 | $3.91 | $3.7569 | $3.775 | 9.57K |
| Oct 6, 2026 | $3.88 | $3.9129 | $3.7701 | $3.84 | 17.22K |
Latest NSRX news
The latest Smart Investors Daily articles mentioning NSRX.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…

